Funding

All articles by Funding

Virtual clinic Pelago raises $58M to expand substance use disorder treatments
Virtual clinic Pelago raises $58M to expand substance use disorder treatments
Jack O'Brien
March 28, 2024
1:23 pm

The additional capital will be utilized to boost Pelago’s substance use disorder treatment offerings and buoy its clinical research efforts.

Cour Pharmaceuticals CEO John Puisis discusses $105M funding round
Cour Pharmaceuticals CEO John Puisis discusses $105M funding round
Jack O'Brien
February 16, 2024
2:10 pm

Puisis recently spoke with MM+M about the funding raise, the condition of the autoimmune treatment space and the potential of Chicago’s ascendant biotech scene.

Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Tome Biosciences CEO Rahul Kakkar on recent $213M funding round
Jack O'Brien
December 19, 2023
10:39 am

MM+M caught up with Kakkar to discuss Tome’s funding effort, the company’s efforts to build upon the progress that’s already been made with CRISPR/Cas9 technology and why the Boston biotech scene has such momentum at its back.

Flagship’s Generate:Biomedicines closes $273M Series C funding round
Flagship’s Generate:Biomedicines closes $273M Series C funding round
Jack O'Brien
September 14, 2023
1:39 pm

This marks Generate:Biomedicines’ first funding round since recording a $370 million Series B financing effort in late 2021.

Rapport Therapeutics brings in $150M Series B funding round
Rapport Therapeutics brings in $150M Series B funding round
Lecia Bushak
August 23, 2023
4:38 pm

Rapport Therapeutics raised $150 million in a Series B round nearly six months after it launched.

Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Janssen emerges as 11th-hour financier for Nanobiotix in $2B+ deal
Marc Iskowitz
July 11, 2023
3:00 pm

Nanobiotix’s financing was set to run out soon. A lucrative licensing deal with Janssen offers a lifeline.

SoftBank-backed ElevateBio touts $401M funding round, Novo partnership
SoftBank-backed ElevateBio touts $401M funding round, Novo partnership
Jack O'Brien
May 24, 2023
12:52 pm

In addition to the funding success, ElevateBio’s subsidiary Life Edit Therapeutics announced that it has signed a multi-target collaboration with Novo Nordisk.

  • From Our Partners